WAM
LUMO

Wolverine Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Wolverine Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,222
Closed -$482K – 1474
2017
Q1 		$482K Buy
+2,222
New +$317K 0.01% 710

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
IFG
Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wolverine Asset Management's LUMO Position: Q1 2020 in Review

Wolverine Asset Management held its Lumos Pharma, Inc. Common Stock (LUMO) position steady in Q1 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

Wolverine Asset Management first reported a position in LUMO in Q3 2014 and has held it in 2 quarters since. The position peaked at $14K in Q3 2014. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

  • Wolverine Asset Management held 0 shares of Lumos Pharma, Inc. Common Stock worth $0 as of Q1 2020.
  • Wolverine Asset Management left its Lumos Pharma, Inc. Common Stock share count unchanged in Q1 2020.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2020, its #1741 holding.
  • Wolverine Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2014 and has held it in 2 quarters since.
  • Wolverine Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $14K in Q3 2014.
  • 46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Wolverine Asset Management's 13F filing for Q1 2020, filed 13 May 2020.